Deep Brain Stimulation of the Subthalamic Nucleus Improves Mood
Laurie Barclay, MD
March 14, 2003 �?Deep brain stimulation (DBS) of the subthalamic nucleus as a treatment for Parkinson's disease (PD) significantly enhances positive mood and emotional memory, according to a report in the March issue of the Archives of General Psychiatry. This observation may advance our understanding of the neurobiological basis of emotions and mood disorders.
"High-frequency electrical stimulation of the subthalamic nucleus is a new and highly effective therapy for complications of long-term levodopa therapy and motor symptoms in advanced PD," write Frank Schneider, MD, PhD, from the University of Düsseldorf in Germany, and colleagues. "Clinical observations indicate additional influence on emotional behavior."
In 12 patients with PD, Dr. Schneider's group compared the effects of DBS of the subthalamic nucleus with those of a suprathreshold dose of levodopa intended to transiently restore striatal dopamine deficiency. During DBS, self-reported mood and emotional memory improved and mood induction effect was enhanced, but cognitive performance did not change. These effects were comparable to those of levodopa.
Study limitations include the time-consuming nature of the experimental procedure, which prevented testing medication effects in randomized order; small sample size; and inability to blind patients to the stimulation state. However, the authors suggest that the affective changes following levodopa or DBS did not simply reflect a reaction to improved motor function.
"DBS of the subthalamic nucleus selectively enhanced affective processing and subjective well-being and seemed to be antidepressive. Levodopa and DBS had similar effects on emotion," the authors write. "This finding may provide new clues about the neurobiologic bases of emotion and mood disorders, and it illustrates the important role of the basal ganglia and the dopaminergic system in emotional processing in addition to the well-known motor and cognitive functions."
Arch Gen Psychiatry. 2003;60:296-302
Reviewed by Gary D. Vogin, MD
=====
|